Publication Type : Journal Article
Publisher : Journal of Clinical and Experimental Hepatology
Source : Journal of Clinical and Experimental Hepatology, Volume 13, Supplement 1, S71-S72, 2023 DOI:https://doi.org/10.1016/j.jceh.2023.07.259
Url : https://www.jcehepatology.com/article/S0973-6883(23)00397-3/
Campus : Kochi
School : School of Medicine
Department : Gastroenterology
Year : 2023
Abstract : Background and Aim: Hepatocellular carcinoma (HCC) represent fifth most common malignancy and the third leading cause of death due to cancer worldwide. Recent data suggest that orally administered systemic therapy (ST) can improve quality of life and survival amongst patients with advanced HCC. Real-world adherence and tolerance to ST are currently unknown outside the clinical trial settings. This study aimed to assess medication adherence, perceived barriers to adherence, and reasons for non-compliance among patients with advanced hepatocellular carcinoma.
Cite this Research Publication : Suja Kumari S, Arun Valsan, Ajee K. L, Nipun Verma, Priya Nair, Shine Sadasivan, K. Pavithran, Sudhindhran S, Merin Babu, Vaishnavy S. Vinod, Krishnapriya, "A prospective study to assess medication adherence to systemic therapy among patients with hepatocellular carcinoma," Journal of Clinical and Experimental Hepatology, Volume 13, Supplement 1, S71-S72, 2023 DOI:https://doi.org/10.1016/j.jceh.2023.07.259